Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00907192 · ClinicalTrials.gov registry record
Self Reported Deviations From Opioid Analgesic Prescription
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 201
- Enrollment target
NCT00907192: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00907192 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 201 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00907192 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 201 participants
- Enrollment target
Study Summary
Primary Objective: 1. To determine the frequency of self-reported over and under use of opioid analgesics in patients with advanced cancer. Patients with advanced cancer are those patients who have been described to have either one of the following: recurrent disease, those that have failed multiple chemotherapies (more than second line therapy), locally advanced disease, and metastatic disease. Secondary Objectives: 1. To determine the association between patients' knowledge, attitudes and beliefs about opioids, and frequency of deviation in opioid use with patients' demographic information. 2. To determine association between alcohol abuse/chemical coping and self-reported deviations in opioid use. 3. To determine the association between the use of opioids and patient-related barriers to opioid use.
Interventions
- BEHAVIORAL Questionnaire
- BEHAVIORAL Personal Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2009-05 |
| Est. Completion | 2012-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00907192
The ClinicalTrials.gov registry entry for NCT00907192 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 201 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire is the first listed.
NCT00907192 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00907192 about?
NCT00907192 is a clinical study titled "Self Reported Deviations From Opioid Analgesic Prescription". Primary Objective: 1. To determine the frequency of self-reported over and under use of opioid analgesics in patients with advanced cancer. Patients with advanced cancer are those patients who have been described to have either one of the following: recurrent disease, those that have failed multipl...
What is the current status of trial NCT00907192?
This trial is currently completed. The enrollment target is 201 participants. The study started on 2009-05. Estimated completion is 2012-06.
What interventions are being tested in trial NCT00907192?
The interventions under investigation include: Questionnaire (BEHAVIORAL), Personal Interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT00907192?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.